Abstract
OBJECTIVES--To assess prospectively the influence of intramuscular gold therapy on Helicobacter pylori serology in patients with rheumatoid arthritis (RA). METHODS--Fifty patients with RA were started on intramuscular gold or chloroquine, as the control group and were followed serologically for H pylori infection for 12 months. RESULTS--Twelve patients treated with gold and eight control patients treated with chloroquine, all with serological evidence for H pylori infection, showed no significant decline of IgA and IgG anti-H pylori antibody levels or serum pepsinogen A and C levels. Total serum IgA and IgG levels declined significantly during gold therapy, while they remained unchanged during chloroquine therapy. CONCLUSIONS--Intramuscular gold therapy in patients with RA does not influence the serological parameters of H pylori infection.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Guslandi M. Still too early for the gold rush. Ann Rheum Dis. 1993 Aug;52(8):623–624. doi: 10.1136/ard.52.8.623-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Taha A. S., Sturrock R. D. The gold plated stomach? Ann Rheum Dis. 1993 Feb;52(2):89–90. doi: 10.1136/ard.52.2.89. [DOI] [PMC free article] [PubMed] [Google Scholar]